» Articles » PMID: 20952405

COSMIC: Mining Complete Cancer Genomes in the Catalogue of Somatic Mutations in Cancer

Abstract

COSMIC (http://www.sanger.ac.uk/cosmic) curates comprehensive information on somatic mutations in human cancer. Release v48 (July 2010) describes over 136,000 coding mutations in almost 542,000 tumour samples; of the 18,490 genes documented, 4803 (26%) have one or more mutations. Full scientific literature curations are available on 83 major cancer genes and 49 fusion gene pairs (19 new cancer genes and 30 new fusion pairs this year) and this number is continually increasing. Key amongst these is TP53, now available through a collaboration with the IARC p53 database. In addition to data from the Cancer Genome Project (CGP) at the Sanger Institute, UK, and The Cancer Genome Atlas project (TCGA), large systematic screens are also now curated. Major website upgrades now make these data much more mineable, with many new selection filters and graphics. A Biomart is now available allowing more automated data mining and integration with other biological databases. Annotation of genomic features has become a significant focus; COSMIC has begun curating full-genome resequencing experiments, developing new web pages, export formats and graphics styles. With all genomic information recently updated to GRCh37, COSMIC integrates many diverse types of mutation information and is making much closer links with Ensembl and other data resources.

Citing Articles

The genomic landscape of metastatic clear-cell renal cell carcinoma and its prognostic value: a comprehensive analysis of a large real-world clinico-genomic database.

Rizzo M, Pezzicoli G, Povero M, Pradelli L, Sicari E, Barbiero V ESMO Open. 2025; 10(3):104294.

PMID: 39965361 PMC: 11876921. DOI: 10.1016/j.esmoop.2025.104294.


Hepatocellular carcinoma: signaling pathways and therapeutic advances.

Zheng J, Wang S, Xia L, Sun Z, Chan K, Bernards R Signal Transduct Target Ther. 2025; 10(1):35.

PMID: 39915447 PMC: 11802921. DOI: 10.1038/s41392-024-02075-w.


Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.

Jadlowsky J, Hexner E, Marshall A, Grupp S, Frey N, Riley J Nat Med. 2025; .

PMID: 39833408 DOI: 10.1038/s41591-024-03478-6.


Investigating the origins of the mutational signatures in cancer.

Boysen G, Alexandrov L, Rahbari R, Nookaew I, Ussery D, Chao M Nucleic Acids Res. 2025; 53(1).

PMID: 39778866 PMC: 11707540. DOI: 10.1093/nar/gkae1303.


Ensemble learning-based predictor for driver synonymous mutation with sequence representation.

Bi C, Shi Y, Xia J, Liang Z, Wu Z, Xu K PLoS Comput Biol. 2025; 21(1):e1012744.

PMID: 39761306 PMC: 11737855. DOI: 10.1371/journal.pcbi.1012744.


References
1.
Forbes S, Bhamra G, Bamford S, Dawson E, Kok C, Clements J . The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet. 2008; Chapter 10:Unit 10.11. PMC: 2705836. DOI: 10.1002/0471142905.hg1011s57. View

2.
Stephens P, McBride D, Lin M, Varela I, Pleasance E, Simpson J . Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature. 2009; 462(7276):1005-10. PMC: 3398135. DOI: 10.1038/nature08645. View

3.
Pleasance E, Cheetham R, Stephens P, McBride D, Humphray S, Greenman C . A comprehensive catalogue of somatic mutations from a human cancer genome. Nature. 2009; 463(7278):191-6. PMC: 3145108. DOI: 10.1038/nature08658. View

4.
Parsons D, Jones S, Zhang X, Cheng-Ho Lin J, Leary R, Angenendt P . An integrated genomic analysis of human glioblastoma multiforme. Science. 2008; 321(5897):1807-12. PMC: 2820389. DOI: 10.1126/science.1164382. View

5.
Ding L, Getz G, Wheeler D, Mardis E, McLellan M, Cibulskis K . Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008; 455(7216):1069-75. PMC: 2694412. DOI: 10.1038/nature07423. View